You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Bulk Pharmaceutical API Sources for IRRIGATING SOLUTION G IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for IRRIGATING SOLUTION G IN PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Get Started Free HkLN@@PiWSR[kVYjjfX@@ ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 251275_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 46933_SUPELCO ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Irrigating Solution G in Plastic Container

Last updated: July 29, 2025

Introduction

The procurement and sourcing of Active Pharmaceutical Ingredients (APIs) for irrigating solutions are critical elements in pharmaceutical manufacturing, particularly for sterile solutions used in medical and surgical applications. Irrigating Solution G, a commonly used sterile solution for wound care, irrigation, and surgical procedures, requires stringent quality standards, stability, and compatibility with plastic containers. This article analyzes the global API suppliers with a focus on bulk sources suitable for manufacturing Irrigating Solution G in plastic packaging, emphasizing quality, regulatory compliance, and supply chain considerations.

Understanding Irrigating Solution G and API Specifications

Irrigating Solution G typically comprises sterile, isotonic solutions, such as sodium chloride, sodium chloride with sterile water, or specific buffer solutions. The API sourcing process involves selecting high-quality, pharmaceutical-grade ingredients complying with pharmacopeial standards (USP, EP, or JP). The API must demonstrate purity, stability, and compatibility with plastic containers to prevent degradation, leaching, or contamination during storage and use.

Key API Components and Sourcing Requirements

  • Sodium Chloride (NaCl): The primary active ingredient in many irrigation solutions.
  • Sterile Water for Injection (WFI): Often used as the diluent in pre-packaged solutions, though sometimes included as an additive component.
  • Buffer Agents: Such as sodium acetate or other buffers, in specific formulations.

For Irrigating Solution G, the APIs must meet stringent sterility standards, pyrogen-free testing, and stability criteria.

Global API Suppliers for Irrigating Solution G

1. Major International API Manufacturers

Leading pharmaceutical ingredient suppliers provide high-quality APIs suitable for sterile irrigation solutions. These manufacturers operate under strict GMP compliance with regulatory approvals from agencies like the FDA, EMA, and PMDA.

  • Fresenius Kabi
    A renowned supplier specializing in sterile and injectable APIs, including sodium chloride and WFI components. They offer bulk APIs with proven stability and compatibility in plastic containers. Their facilities adhere to the highest GMP standards, making them suitable for sterile irrigating solutions.

  • Sigma-Aldrich/Merck KGaA
    Offers a broad portfolio of pharmaceutical-grade APIs, including sodium chloride, sterile water, and buffers. Their APIs undergo rigorous quality control, ensuring suitability for sterile, single-use plastic containers used in irrigation solutions.

  • BASF SE
    Provides chemical-grade and pharmaceutical-grade APIs, notably sodium chloride, with extensive manufacturing experience in sterile and parenteral-grade ingredients. Their products are compliant with pharmacopeial standards and are used globally in irrigating solutions.

  • Samsung Fine Chemicals
    Supplies pharmaceutical-grade sodium chloride and related APIs. Their manufacturing processes focus on purity and sterile specifications, with supply chains aligned for sterile, injectable-grade APIs.

  • USP/NF and EP Monograph-Compliant Suppliers
    Numerous domestic and international manufacturers produce APIs compliant with USP and EP monographs, ensuring market acceptance and regulatory approval. Examples include LGM Pharma, Cambridge Isotope Laboratories, and Siegfried, which provide high-purity APIs suitable for sterile solutions.

2. Regional API Suppliers

  • India:
    Indian pharmaceutical companies such as Sun Pharmaceutical Industries, Gufic Biosciences, and Hospira India produce GMP-compliant APIs for irrigation solutions, with cost advantages and established export channels. Many of these suppliers hold WHO-GMP certification, making them suitable for global markets.

  • China:
    Leading producers like Hefei Reddog Biotechnology, Shandong Xinhua Pharmaceutical, and Sichuan Kelun Pharmaceutical supply APIs such as sodium chloride at competitive prices. Their facilities increasingly meet international standards, although verification of GMP compliance and regulatory audits is essential before procurement.

  • European Manufacturers:
    European suppliers like Lachema and Fresenius Kabi emphasize rigorous quality standards, ensuring APIs suitable for sterile irrigation solutions meet the highest pharmacopeial specifications.

Key Criteria for API Selection for Irrigating Solution G

  • GMP Compliance and Regulatory Standing
    Suppliers must demonstrate compliance with GMP standards and possess relevant regulatory approvals to mitigate risks of contamination, pyrogens, or impurities.

  • Purity and Quality Standards
    APIs should conform to pharmacopoeial monographs, including limits for endotoxins and residual solvents, aligning with USP, EP, or JP guidelines.

  • Supply Stability and Scalability
    Reliable supply chains with ability to scale production are critical to meet continuous demand for irrigating solutions in hospitals and surgical centers.

  • Compatibility with Plastic Containers
    APIs should have demonstrated stability and compatibility in plastic containers, avoiding interactions that could compromise sterility or efficacy.

  • Cost and Lead Time
    Cost-effectiveness and consistent lead times impact procurement strategies, especially during supply chain disruptions or global shortages.

Emerging Trends and Considerations

  • Regulatory Harmonization
    With increasing global demand, suppliers that can align with multiple regulatory standards (FDA, EMA, WHO) provide more flexible sourcing options.

  • Supply Chain Resilience
    Diversification of suppliers across regions reduces geopolitical and pandemic-related risks. Building strategic relationships with multiple approved suppliers enhances supply security.

  • Sustainability and Green Manufacturing
    Environmentally conscious production practices are gaining importance, influencing supplier selection criteria.

Conclusion

Procurement of bulk APIs for Irrigating Solution G in plastic containers requires meticulous supplier selection based on regulatory compliance, quality standards, and supply reliability. Globally, reputable companies in North America, Europe, and Asia offer pharmaceutical-grade APIs that meet stringent pharmacopeial standards, suitable for sterile, single-use irrigation solutions. Establishing strategic partnerships with these suppliers ensures a consistent supply chain, product safety, and regulatory compliance, enabling manufacturers to deliver safe and effective irrigating solutions worldwide.


Key Takeaways

  • Select API suppliers with proven GMP compliance, regulatory approvals, and a track record in sterile pharmaceuticals.
  • Prioritize suppliers offering APIs with validated stability and compatibility for use in plastic containers.
  • Diversify sourcing across regions to mitigate supply disruptions.
  • Maintain rigorous quality control, including endotoxin and sterility verification, for APIs used in irrigating solutions.
  • Monitor evolving regulatory requirements and sustainability practices to align sourcing strategies.

Frequently Asked Questions (FAQs)

Q1. What are the primary active ingredients used in Irrigating Solution G?
A1. The main active ingredient is typically sodium chloride, often in sterile water for injection, with possible buffers depending on formulation requirements.

Q2. How do I verify the quality of APIs sourced for sterile irrigation solutions?
A2. Verify supplier GMP certification, review COAs (Certificates of Analysis), ensure compliance with pharmacopeial standards (USP, EP, JP), and conduct in-house or third-party testing for endotoxins and sterility.

Q3. Which regions offer the most reliable suppliers of pharmaceutical-grade APIs for irrigating solutions?
A3. North America (USA and Canada), Europe (Germany, Switzerland), and Asia (India, China) have established reputable API manufacturers with varying cost and regulatory profiles.

Q4. What are the considerations for API stability in plastic containers?
A4. APIs should have demonstrated chemical stability, minimal leaching or interaction with plastics, and compatibility data ensuring efficacy during storage and use.

Q5. How can supply chain risks be mitigated when sourcing APIs for sterile solutions?
A5. Diversify suppliers across regions, establish long-term agreements, maintain safety stock levels, and conduct regular supplier audits to ensure quality and supply continuity.


References

[1] U.S. Pharmacopeia. USP monographs for Sodium Chloride and Water for Injection.
[2] European Pharmacopoeia. General chapters and monographs for sterile pharmaceuticals.
[3] WHO Drug Information. Standards for sterile injectable APIs.
[4] GlobalData. API market analysis report, 2022.
[5] Industry reports on API supplier compliance and quality standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.